|
1.
Share Success: Letters From Readers
***************************************************
Letter
I: From Ruth
Received
at Testimonial
Submit Form on Wednesday, June 27, 2007 at
09:10:29
Hi,
my name is Ruth. I was told I had Fibromyalgia Oct.
'05. Did extensive research and found EZorb. I started
taking it Oct. 17th, '05. Started with a personal
trainer Oct. 28th. My knees and hands were so swollen
I had my rings changed from a size 6 to a size 9. I
could hardly walk, had to rest often, was walking at
least one mile, or more a day, had to stop that. Had
to stop working in my yard, cleaning the house now
took three or four days instead of one. Just being
awake was painful. Sleeping was impossible. I thought
my life was over.
I
kept in touch with a very helpful gentleman P.Z. at
the Elixir Industry about EZorb
and what effect it was
having on me. He would tell me to continue to take it
twice a day and I would see results. At times I had no
hope of ever getting better but did continue taking
it.
My
personal trainer said she could help me with
fibromyalgia but she thought I had rheumatiod artritis
also. Went to a specialist and indeed I do have both.
She said I needed more help than she could give me. I
tried other medications for a while but was getting
nowhere.
Started
wtih another personal trainer and stayed with the EZorb. The personal trainer told me of a health food
product. In a matter of weeks the swelling had gone
away and some of the pain. I continued to talk to the
gentleman about EZorb
and he said I would start
feeling lots better.
I
am so happy I listened to him and stayed with my
program. EZorb
is something that helped give me my
life back and I will continue to take it the rest of
my life.
I
am not walking as much as I would like but I am able
to work with the personal trainer two times a week now
and feel better for it. Sleep much better and am
enjoying life a lot more.
The
best report I can give about EZorb
is: Seven years ago
I had a bone density test. I was told then I head
osteroporosis and needed to take medication. I tried
that and the side effects were not good. Took what I
thought was an excellent
calcium not knowing about EZorb
at that time. I just had another bone density
test and my report is too good to believe. My bone
density has stayed the same as it was seven years ago.
The doctor could hardly believe it due to the fact
that I am seven years older and that makes me the
young age of 76 years. Needless to say EZorb
and
exercise are a part of my life from now on. I am so
grateful P.Z., with EZorb, was so patient with me and
that I listened to him. I could have given up and he
could have also.
I
have recommended this product to so many people and
will continue to do so. Thank you so much.
Ruth
Letter
II: From E. Anonymous
Received
at Testimonial
Submit Form on Tuesday, May 15, 2007 at 14:15:56
(Unedited)
I
cannot thank you enough for your EZorb
capsules. I've
been using them for almost 3 weeks and though my heel
isn't completely better, I am able to walk without
sharp pain. I was desperate to find something that
helped. Your product also arrived within 3 days of
when I ordered it. I expected to have to wait weeks.
Thanks!!!
Letter
III: From Donna, Bloomington, IL
Received
at Testimonial
Submit Form on Tuesday, March 06, 2007 at 11:33:19
(Unedited)
Hi,
my name is Donna. I'm 53 years old and have been
diagnosed with ostio. I too was offered fasomax. I
refused and found EZorb
over the internet. I'm
postmenopausal and also refused to take hormone
thearpy. My obgyn didn't even take a bone denisty test
on me but offered treatment to prevent me from getting
ostio.
I'm
glad I refused. Since taking EZorb
I have notice my
nails getting really long and not brittle. I have
never had long nails in my life and they were always
brittle. I'm looking forward to getting another bone
density test. I have much more energy and also am
sleeping better at night. I'm also not having nearly
as many hot flashes. Thank-you ezorb.
Donna
Bloomington,
Il
Letter
IV: From Lorraine, Detroit, MI
Received
at Testimonial
Submit Form on Tuesday, January 30, 2007 at
13:43:50
(Unedited)
Hi,
my name is Lorraine. My bone density test resulted in
2.1 from 2.5 after I started taking EZorb. My doctor
said I'm so pleased with you. He is still writing me
prescriptions for Fosomex which I haven't taken since
I discovered EZorb.
Detroit, Michigan
***************************************************
From
the Desk of EZorb Newsletter Editor:
This
newsletter is now read by over 50,000 subscribers
worldwide. Success stories you contribute will have
great impact on many people's life. Kindly email your
story to sharesuccess @ elixirindustry.com.
As always your private information will never be
revealed to the public.
2.
Research News: Two Diabetes Drugs Double Heart Failure
Risk
Patients
taking either of the diabetes drugs Avandia or Actos
face twice the risk of developing heart failure
compared to people not on the popular medications, a
new study finds.
This
means for every 50 patients with type 2 diabetes
taking these drugs, one patient will develop heart
failure within 26 months, according to the report
released Friday and published in the August issue of
Diabetes Care.
"Both
Avandia and Actos double the risk of heart
failure," concluded the lead author of the first
study, Dr. Sonal Singh, an assistant professor of
internal medicine at Wake Forest University School of
Medicine. "We know these drugs increase the risk,
but we found the risk is more substantial than
suspected. This occurs at even the lowest dose and
among young patients."
The
report follows a U.S. government review released
Thursday that found Avandia's heart risks are far
higher than Actos'. That report sets the stage for an
advisory panel hearing Monday that will examine
whether Avandia's cardiovascular risks warrant a
stronger warning label.
Avandia
(rosiglitazone) and Actos (pioglitazone) are from the
same family of diabetes drugs and used by more than 3
million diabetic patients across the United States.
The
current product label warns against using these drugs
in patients with more severe cases of heart failure.
The label also warns that there is an increased risk
of heart failure if the drugs are used in combination
with insulin.
Singh's
group, however, found that the risk wasn't limited to
patients on insulin, and it was present even among
patients without any risk factors for heart failure.
The
government study, by a medical and safety review team
at the Food and Drug Administration, found that
patients are at much higher risk of heart problems if
they take Avandia, compared to patients taking Actos.
Avandia is especially hazardous to patients who are
already on insulin, the report found, whereas Actos
users can take insulin as well without fearing cardiac
side effects, the New York Times reported.
That
data could help decide whether or not Avandia remains
on drug store shelves, experts said.
"A
critical question to be resolved in determining
appropriate regulatory action is whether the
anticipated therapeutic benefit of rosiglitazone
outweighs the demonstrated cardiovascular risk,"
one FDA reviewer concluded according to the Times
report.
In
the Diabetes Care study, Singh's team collected data
on more than 78,000 patients taking either of the
drugs. These patients were included in previously
published studies and in case reports. Not only did
the drugs double the risk of heart failure, but the
increased risk was seen with both high and low doses,
the team found.
Heart
failure developed in some patients taking lower doses
than are commonly prescribed. The average time for
heart failure to develop was 24 weeks after starting
the drugs, the researchers found.
Heart
failure wasn't confined to older patients. Twenty-five
percent of the patients who developed heart failure
were under 60. In addition, both men and women
developed heart failure while taking the drugs, Singh
noted.
Singh's
group suspect that Avandia and Actos may boost heart
failure risk by encouraging fluid retention.
Current
guidelines allow the use of these drugs in patients
with early-stage heart failure. "Based on our
information, that may have to change," Singh
said.
Singh
noted that there are alternative drugs available.
"Doctors should be aware of the risk," he
said. "Patients who are on these drugs and start
developing symptoms of heart failure should see their
doctor immediately, and patients not on these drugs
should look at alternatives."
One
expert believes that patients taking Avandia and Actos
face not only an increased risk of heart failure, but
also a 43 percent increased risk of heart attack.
"This
hazard of heart failure is pretty well known for these
drugs," said Dr. Steven E. Nissen, chairman of
the department of cardiovascular medicine at the
Cleveland Clinic. He noted that, in May, the FDA said
it was going to mandate a "black box"
warning about heart failure risk on the labels of
these drugs.
That
same month, Nissen published a paper in the New
England Journal of Medicine that found that Avandia
increased the risk of heart attack.
Since
then, the controversy has continued, with both sides
weighing in.
On
Thursday, Mary Anne Rhyne, a spokeswoman for
GlaxoSmithKline, which makes Avandia, responded to the
new government review by saying the company continued
to believe Avandia was safe, the Times reported.
"Across
the extensive data we have, the science shows no
increase in cardiovascular death, and does not support
a difference in heart attack rates between Avandia and
the other most commonly prescribed oral
antidiabetics," Rhyne told the Times.
On
Friday, the company's director of clinical
development, Dr. Andy Zambanini, told HealthDay that
Glaxo was "still in negotiation with the FDA
about a new warning label on heart failure, and we
expect to release that information soon."
Nissen
believes that patients who are considering taking
Avandia should discuss the decision with their doctor.
"It is important that the totality of information
be out there," he said. "But no patient
should stop taking a medication [only] because they
read a news report."
Another
expert contends that the two drugs are safe if
prescribed correctly.
"The
risk for heart failure with these drugs may be one in
50, but if you can correctly identify who that person
[at risk] is, you can safely treat the other 49 and
not hurt anybody," said Dr. Larry Deeb, president
for medicine and science at the American Diabetes
Association.
Deeb
believes the same holds true for the risk of heart
attack.
The
boost in risk of heart failure and heart attack does
not warrant taking these drugs off the market, he
added.
"They
fit into the armamentarium of diabetes drugs if used
properly," Deeb said.
Original
Study Published in August issue of Diabetes Care
3.
Useful Links
EZorb
Online
Frequently
Asked Questions & Answers
EZorb
Clinical Studies
Marvlix
Benefits
Order
Now
4.
Calcium
Absorption Test
EZorb
Calcium has set a new world record of absorption rate.
You can compare EZorb
with other calcium supplements
by using the simple step-by-step instructions we
provide. E-mail your request to test @
elixirindustry.com
for a copy of the instructions.
5.
What Are Others Saying About EZorb?
EZorb
Calcium has restored confidence in thousands of men
and women. It has brought happiness and healthy life
to families around the world. Click here
to read what people say about EZorb. |
